(PINC) Premier - Ratings and Ratios
Group Buying, Software Analytics
PINC EPS (Earnings per Share)
PINC Revenue
Description: PINC Premier
Premier Inc (NASDAQ:PINC) is a US-based healthcare services company. As a leading healthcare services provider, the companys performance is closely tied to the overall healthcare landscape, including trends in healthcare spending, regulatory changes, and shifts in care delivery models.
Key drivers of PINCs financial performance include revenue growth, driven by the companys ability to expand its services and customer base, as well as its ability to manage costs and maintain profitability. Return on Equity (ROE) of 3.49% suggests that the company is generating relatively modest returns for shareholders, potentially indicating a need for improvement in capital allocation or profitability.
The stocks valuation, as reflected in its Price-to-Earnings (P/E) ratio of 21.10 and Forward P/E of 15.17, suggests that investors have moderate expectations for the companys future earnings growth. The relatively low Beta of 0.545 indicates that PINCs stock price tends to be less volatile than the broader market, potentially making it a more attractive option for risk-averse investors.
To drive future growth, PINC will likely need to focus on expanding its services, improving operational efficiency, and navigating the complex healthcare regulatory environment. Key Performance Indicators (KPIs) to watch include revenue growth rate, customer acquisition costs, and operating margin expansion. Additionally, the companys ability to adapt to changes in healthcare policy and reimbursement rates will be critical to its long-term success.
PINC Stock Overview
| Market Cap in USD | 2,138m |
| Sub-Industry | Health Care Services |
| IPO / Inception | 2013-09-26 |
PINC Stock Ratings
| Growth Rating | 0.33% |
| Fundamental | 53.2% |
| Dividend Rating | 69.4% |
| Return 12m vs S&P 500 | 12.6% |
| Analyst Rating | 2.88 of 5 |
PINC Dividends
| Dividend Yield 12m | 3.53% |
| Yield on Cost 5y | 3.17% |
| Annual Growth 5y | 17.19% |
| Payout Consistency | 99.2% |
| Payout Ratio | 61.8% |
PINC Growth Ratios
| Growth Correlation 3m | 66.8% |
| Growth Correlation 12m | 51% |
| Growth Correlation 5y | -73.9% |
| CAGR 5y | -5.18% |
| CAGR/Max DD 3y | -0.11 |
| CAGR/Mean DD 3y | -0.15 |
| Sharpe Ratio 12m | -0.13 |
| Alpha | 32.74 |
| Beta | 0.129 |
| Volatility | 24.88% |
| Current Volume | 897.7k |
| Average Volume 20d | 1614k |
| Stop Loss | 25.8 (-3%) |
| Signal | -0.32 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (20.3m TTM) > 0 and > 6% of Revenue (6% = 60.8m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 3.94pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -33.93% (prev -0.41%; Δ -33.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 401.4m > Net Income 20.3m (YES >=105%, WARN >=100%) |
| Net Debt (207.7m) to EBITDA (138.0m) ratio: 1.50 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (83.6m) change vs 12m ago -20.84% (target <= -2.0% for YES) |
| Gross Margin 72.47% (prev 62.78%; Δ 9.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 30.93% (prev 37.64%; Δ -6.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.18 (EBITDA TTM 138.0m / Interest Expense TTM 17.2m) >= 6 (WARN >= 3) |
Altman Z'' -1.51
| (A) -0.11 = (Total Current Assets 567.0m - Total Current Liabilities 910.6m) / Total Assets 3.12b |
| (B) -0.16 = Retained Earnings (Balance) -485.0m / Total Assets 3.12b |
| (C) 0.01 = EBIT TTM 20.4m / Avg Total Assets 3.27b |
| (D) -0.30 = Book Value of Equity -484.2m / Total Liabilities 1.59b |
| Total Rating: -1.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 53.15
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 10.55% = 5.0 |
| 3. FCF Margin 31.48% = 7.50 |
| 4. Debt/Equity 0.63 = 2.31 |
| 5. Debt/Ebitda 7.01 = -2.50 |
| 6. ROIC - WACC -3.81% = -4.77 |
| 7. RoE 1.21% = 0.10 |
| 8. Rev. Trend -74.36% = -3.72 |
| 9. Rev. CAGR -6.25% = -1.04 |
| 10. EPS Trend -29.34% = -0.73 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of PINC shares?
Over the past week, the price has changed by -1.88%, over one month by +8.87%, over three months by +20.24% and over the past year by +33.11%.
Is Premier a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PINC is around 27.86 USD . This means that PINC is currently overvalued and has a potential downside of 4.74%.
Is PINC a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the PINC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.5 | -4.1% |
| Analysts Target Price | 25.5 | -4.1% |
| ValueRay Target Price | 30 | 12.7% |
Last update: 2025-09-02 02:47
PINC Fundamental Data Overview
CCE Cash And Equivalents = 83.7m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 38.0882
P/E Forward = 18.3824
P/S = 2.1113
P/B = 1.3969
P/EG = 1.6295
Beta = 0.543
Revenue TTM = 1.01b USD
EBIT TTM = 20.4m USD
EBITDA TTM = 138.0m USD
Long Term Debt = 678.0m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 289.4m USD (from shortTermDebt, last quarter)
Debt = 967.4m USD (Calculated: Short Term 289.4m + Long Term 678.0m)
Net Debt = 207.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.02b USD (2.14b + Debt 967.4m - CCE 83.7m)
Interest Coverage Ratio = 1.18 (Ebit TTM 20.4m / Interest Expense TTM 17.2m)
FCF Yield = 10.55% (FCF TTM 318.8m / Enterprise Value 3.02b)
FCF Margin = 31.48% (FCF TTM 318.8m / Revenue TTM 1.01b)
Net Margin = 2.00% (Net Income TTM 20.3m / Revenue TTM 1.01b)
Gross Margin = 72.47% ((Revenue TTM 1.01b - Cost of Revenue TTM 278.8m) / Revenue TTM)
Tobins Q-Ratio = -6.24 (set to none) (Enterprise Value 3.02b / Book Value Of Equity -484.2m)
Interest Expense / Debt = 0.65% (Interest Expense 6.30m / Debt 967.4m)
Taxrate = 25.82% (25.3m / 98.0m)
NOPAT = 15.1m (EBIT 20.4m * (1 - 25.82%))
Current Ratio = 0.62 (Total Current Assets 567.0m / Total Current Liabilities 910.6m)
Debt / Equity = 0.63 (Debt 967.4m / last Quarter total Stockholder Equity 1.53b)
Debt / EBITDA = 7.01 (Net Debt 207.7m / EBITDA 138.0m)
Debt / FCF = 3.03 (Debt 967.4m / FCF TTM 318.8m)
Total Stockholder Equity = 1.68b (last 4 quarters mean)
RoA = 0.65% (Net Income 20.3m, Total Assets 3.12b )
RoE = 1.21% (Net Income TTM 20.3m / Total Stockholder Equity 1.68b)
RoCE = 0.86% (Ebit 20.4m / (Equity 1.68b + L.T.Debt 678.0m))
RoIC = 0.80% (NOPAT 15.1m / Invested Capital 1.88b)
WACC = 4.62% (E(2.14b)/V(3.11b) * Re(6.49%)) + (D(967.4m)/V(3.11b) * Rd(0.65%) * (1-Tc(0.26)))
Shares Correlation 3-Years: -66.67 | Cagr: -3.24%
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 77.49% ; FCFE base≈277.4m ; Y1≈263.1m ; Y5≈251.0m
Fair Price DCF = 54.35 (DCF Value 4.49b / Shares Outstanding 82.5m; 5y FCF grow -6.72% → 3.0% )
Revenue Correlation: -74.36 | Revenue CAGR: -6.25%
Rev Growth-of-Growth: -14.88
EPS Correlation: -29.34 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 18.31
Additional Sources for PINC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle